Dishman Carbogen Amcis Limited

NSE DCAL.NS

Dishman Carbogen Amcis Limited Return on Capital Employed (ROCE) for the year ending March 31, 2024: -0.05%

Dishman Carbogen Amcis Limited Return on Capital Employed (ROCE) is -0.05% for the year ending March 31, 2024, a -114.90% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Dishman Carbogen Amcis Limited Return on Capital Employed (ROCE) for the year ending March 31, 2023 was 0.35%, a -42.23% change year over year.
  • Dishman Carbogen Amcis Limited Return on Capital Employed (ROCE) for the year ending March 31, 2022 was 0.61%, a 299.99% change year over year.
  • Dishman Carbogen Amcis Limited Return on Capital Employed (ROCE) for the year ending March 31, 2021 was -0.30%, a -107.81% change year over year.
  • Dishman Carbogen Amcis Limited Return on Capital Employed (ROCE) for the year ending March 31, 2020 was 3.89%, a -33.22% change year over year.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
Loading...
SV Wall Street
NSE: DCAL.NS

Dishman Carbogen Amcis Limited

CEO Mr. Pascal Villemagne
IPO Date April 22, 2004
Location India
Headquarters Dishman Corporate House
Employees 1,132
Sector Consumers Staples
Industries
Description

Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, intermediates, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitisers, antiseptics, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was incorporated in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.

Similar companies

SHILPAMED.NS

Shilpa Medicare Limited

USD 8.18

0.56%

CAPLIPOINT.NS

Caplin Point Laboratories Limited

USD 23.91

2.07%

BLISSGVS.NS

Bliss GVS Pharma Limited

USD 1.72

-4.39%

INDOCO.NS

Indoco Remedies Limited

USD 2.88

1.89%

ERIS.NS

Eris Lifesciences Limited

USD 14.15

2.83%

StockViz Staff

February 3, 2025

Any question? Send us an email